HEALTHCARE, BIOTECH & PHARMA
The US healthcare sector encompasses a wide range of establishments, including hospitals, clinics, physicians, specialists, and allied health professionals, with a combined annual revenue of approximately $2.5 trillion. Health spending in the US is among the highest in the world, involving government programs, insurance premiums, and out-of-pocket expenses.
Our healthcare team focuses on management services, medical devices, biotechnology and pharmaceutical product manufacturing, and specialized services in various fields. We do not cover R&D, trial-based, or VC-backed healthcare companies.
TRENDS & CHALLENGES
Health disparities and unequal access to quality healthcare remain challenges in the US, leading to higher rates of chronic conditions and health disparities among certain populations.
The affordability of healthcare services, including insurance premiums and out-of-pocket costs, poses difficulties for many Americans, particularly those in low-income communities. Integrating health information technology and ensuring interoperability, data privacy, and security are ongoing challenges in the US healthcare system.
The use of wearable devices and precision medicine holds the potential to transform healthcare delivery, diagnosis, treatment, and personalized care, leading to better patient outcomes and improved disease prevention and management. Focus on prevention and population health management is crucial, with an emphasis on addressing social determinants of health, promoting healthy lifestyles, and targeting at-risk populations.
Changes in federal and state healthcare policy and legislation will significantly impact the future of healthcare in the US, shaping access, affordability, coverage, and sustainability.
6 to 13X
Disclosure: These key performance indicators are based on industry averages for a company with $10 million in revenue. The KPIs are not specific to the operational performance of your company or your sub-sector.
The information contained has been obtained from different sources deemed reliable, including DealStats, Deloitte, Dun & Bradstreet, and Business Reference Guide. Pacifica Advisors does not make any representation or warranty as to the accuracy of the data. PA is a mergers and acquisitions (M&A) advisor and business broker.